Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII | NASDAQ
$10.20
$0.00 (0.00%)
At close: Oct 30, 2026, 3:59 PM ET
$10.19
-$0.01 (-0.10%)
After-hours:
Oct 30, 2026, 4:02 PM ET
+0.00%
(1D)No price chart data available for 1D timeframe.
Rating
34.8
+14.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1024/1279 (Top 80%)
Key Statistics
Market Data
Market Cap $649.74M
1D Range
10.20 10.21
52W Range
9.87 10.21
Valuation (TTM)
PE 35.17
PB 1.31
EV/EBITDA -449.11
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -0.2%
SBC Adj. FCF Yield -0.2%
SBC Impact N/A
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y N/A |
N/A
FCF 3Y | 5Y N/A |
N/A
Returns
ROA 2.5%
ROE 2.7%
ROIC -0.3%
Financial Health
Net Debt
$275.03K
Current Ratio 0.34
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an a...
Sector Financial Services
Industry Financial - Conglomerates
Employees 2
IPO Date Dec 4, 2025
Website dmaacorp.com/
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove DMII